계정 가입
email 로 로그인
email 로 가입
수신함을 확인하세요
Kringle Pharma
About
Kringle Pharma is a biopharmaceutical company.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- ¥740M
- Industries
- Biotechnology,Medical,Nursing and Residential Care,Pharmaceutical
- Founded date
- Dec 21, 2001
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Kringle Pharma, Inc., a biopharmaceutical company, develops pharmaceutical products based on its research on hepatocyte growth factor (HGF) and NK4. Its HGF has the regenerative healing ability in regard to liver cells, as well as various cells and organs; and NK4 is a bi-functional molecule, which inhibits the invasion and metastasis of tumor cells as an HGF-antagonist, as well as possesses antiangiogenic activity. The company’s pipeline includes recombinant human HGF for the treatment of acute renal failure, skin ulcers, and CNS diseases; and recombinant human NK4 and NK4 gene drugs for cancer therapy. Kringle Pharma, Inc. was founded in 2001 and is based in Toyonaka, Japan.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 4, 2020 | Series Unknown | ¥740M | 2 | — | — | Detail |
| Feb 28, 2020 | Series Unknown | ¥0.95B | 1 | — | — | Detail |
| Dec 5, 2016 | Series Unknown | ¥610M | 1 | — | — | Detail |
| Dec 4, 2007 | Series Unknown | ¥1.06B | 1 |
Nissei Capital
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Nissei Capital
|
Yes | Series Unknown |
Chishima Real Estate
|
— | Series Unknown |
|
|
— | Series Unknown |
|
|
— | Series Unknown |
Gogin Capital
|
— | Series Unknown |
